Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Pursuant to ....
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indraprastha Medical Corporation Ltd (Indraprastha Apollo Hospitals) has informed exchanges that a Board meeting is scheduled for 12 May 2026. The meeting will consider and approve the audited financial results for the quarter and year ended 31 March 2026. Additionally, the Board will consider and recommend a dividend on equity shares for FY 2025-26. The filing is made under SEBI Regulation 29 and was signed by Priya Ranjan, AVP – Corporate Affairs & Legal and Company Secretary, on 1 May 2026. The company is listed on BSE (Scrip Code: 532150) and NSE (Symbol: INDRAMEDCO).
This is a routine pre-result announcement notice. Investors should note the scheduled date for Q4/FY2026 results and any dividend announcement, which could positively influence the stock if earnings or dividends meet expectations.